Literature DB >> 1971828

T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease.

D N Posnett1, I Schmelkin, D A Burton, A August, H McGrath, L F Mayer.   

Abstract

Crohn's disease represents part of a spectrum of inflammatory bowel diseases characterized by immune regulatory defects and genetic predisposition. T cell antigen receptor V gene usage by T lymphocytes was investigated using four MAbs specific for various V gene products. One MAb (Ti3a), reactive with V beta 8 gene products, detected increased numbers of T cells in a subset of Crohn's disease patients as compared with normal controls and ulcerative colitis patients. In family studies there was no apparent inherited predisposition to the use of V beta 8 genes, and there was no association between a restriction fragment length polymorphism of the V beta 8.1 gene and Crohn's disease. The V beta 8+ T cells were concentrated in the mesenteric lymph nodes draining the inflammatory lesions and belonged to both the CD4+ and CD8+ T cell subsets. In contrast, lamina propria and intraepithelial T cells were not enriched in V beta 8+ T cells, suggesting that these cells were participating in the afferent limb of a gut-associated immune response. The expanded V beta 8+ T cells in Crohn's disease appear to result from an immune response to an as yet unknown antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971828      PMCID: PMC296639          DOI: 10.1172/JCI114634

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL.

Authors:  S Carrel; P Isler; M Schreyer; A Vacca; S Salvi; L Giuffre; J P Mach
Journal:  Eur J Immunol       Date:  1986-06       Impact factor: 5.532

2.  Stimulation and expansion of a human T-cell subpopulation by a monoclonal antibody to T-cell receptor molecule.

Authors:  C Y Wang; Y Bushkin; R Pica; C Lane; H McGrath; D N Posnett
Journal:  Hybridoma       Date:  1986

3.  Correlations between T-cell specificity and the structure of the antigen receptor.

Authors:  P J Fink; L A Matis; D L McElligott; M Bookman; S M Hedrick
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

4.  Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones.

Authors:  U Hochgeschwender; H U Weltzien; K Eichmann; R B Wallace; J T Epplen
Journal:  Nature       Date:  1986 Jul 24-30       Impact factor: 49.962

5.  Inherited polymorphism of the human T-cell antigen receptor detected by a monoclonal antibody.

Authors:  D N Posnett; C Y Wang; S M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

Review 6.  Epidemiology of inflammatory bowel disease.

Authors:  B M Calkins; A I Mendeloff
Journal:  Epidemiol Rev       Date:  1986       Impact factor: 6.222

7.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

Authors:  A Weiss; J D Stobo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

8.  Dissection of the human antigammaglobulin idiotype system with monoclonal antibodies.

Authors:  D N Posnett; R Wisniewolski; B Pernis; H G Kunkel
Journal:  Scand J Immunol       Date:  1986-02       Impact factor: 3.487

9.  Analysis of a human V beta gene subfamily.

Authors:  G Siu; E C Strauss; E Lai; L E Hood
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  T cell antiidiotypic antibodies reveal differences between two human leukemias.

Authors:  D N Posnett; R D Bigler; Y Bushkin; D E Fisher; C Y Wang; L F Mayer; N Chiorazzi; H G Kunkel
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  29 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  A persistent T cell expansion in the peripheral blood of a normal adult male: a new clinical entity?

Authors:  J Grunewald; M Jeddi-Tehrani; H Dersimonian; R Andersson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

3.  Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever.

Authors:  W G Abbott; M A Skinner; L Voss; D Lennon; P L Tan; J D Fraser; I J Simpson; R Ameratunga; A Geursen
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal.

Authors:  Y Uematsu; H Wege; A Straus; M Ott; W Bannwarth; J Lanchbury; G Panayi; M Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 5.  Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease.

Authors:  J P Ibbotson; J R Lowes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 6.  The potential role of superantigens in inflammatory bowel disease.

Authors:  R A Kay
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 7.  Evidence for a superantigen in the pathogenesis of tuberculosis.

Authors:  J D Ohmen; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

9.  Restricted V beta gene usage of tumour-infiltrating T lymphocytes in primary gastric malignant B-cell lymphoma.

Authors:  N Yumoto; A Araki; T Sumida; T Saito; M Taniguchi; A Mikata
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  T-cell receptor V beta chain expression in patients with juvenile rheumatoid arthritis.

Authors:  G Horneff; M Hanson; V Wahn
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.